Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
12.64
-0.06 (-0.47%)
At close: Jun 12, 2026, 4:00 PM EDT
12.71
+0.07 (0.55%)
After-hours: Jun 12, 2026, 7:21 PM EDT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $214.33 million as of June 12, 2026. Its market cap has increased by 829.70% in one year.
Market Cap
214.33M
Enterprise Value
177.22M
1-Year Change
829.70%
Ranking
Category
Stock Price
$12.64
Market Cap Chart
Since March 26, 2024, Q32 Bio's market cap has increased from $199.19M to $214.33M, an increase of 7.60%. That is a compound annual growth rate of 3.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 214.33M | 424.67% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 219.48M |
| Codexis | 218.15M |
| Canton Strategic Holdings | 216.05M |
| Coherus Oncology | 215.18M |
| Cybin | 215.15M |
| ALX Oncology Holdings | 213.95M |
| Karyopharm Therapeutics | 213.56M |
| LENZ Therapeutics | 213.21M |